Peter E. Boyd
Chief People Officer at Aquestive Therapeutics, Inc. (AQST)
Peter E. Boyd has filed 20 insider reports with the SEC since March 2021, as chief People Officer at Aquestive Therapeutics, Inc. (AQST). In the last 12 months Peter E. Boyd sold $124K of stock on the open market. The latest filing, on September 10, 2026, reports exercise of an in-the-money derivative at Aquestive Therapeutics, Inc. (AQST).
- Filings
- 20
- Companies
- 1
- Bought on market
- $6,251
- Sold on market
- $337K
Companies where Peter E. Boyd is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, Inc. | Chief People Officer | 284,024 | $6,251 | $337K | $0.86 | $3.54+312% | Sep 10, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 9, 2026AQSTChief People Officer Boyd Peter E. exercised 2,293 in-the-money shares at a strike of $0.96, increasing direct ownership by 0.81% to 284,024 unitsForm 4Exercise of an in-the-money derivative
- May 5, 2026AQSTChief People Officer Boyd Peter E. covered exercise/tax liability with 56,778 shares, decreasing direct ownership by 17% to 281,731 units (for tax liability)Form 4Shares withheld for taxes or exercise price
- Mar 7, 2025AQSTSEC Form 4 filed by Boyd Peter E.Form 4Grant or award
- Mar 10, 2026-$124KAQSTChief People Officer Boyd Peter E. was granted 80,000 shares and sold $124,414 worth of shares (29,814 units at $4.17), increasing direct ownership by 17% to 338,509 unitsForm 4Grant or awardOpen-market sale
- Dec 4, 2025AQSTChief People Officer Boyd Peter E. was granted 20,000 shares, increasing direct ownership by 7% to 288,323 unitsForm 4Grant or award
- Oct 15, 2025-$70KAQSTOfficer Boyd Peter E. sold $70,000 worth of shares (10,000 units at $7.00), decreasing direct ownership by 4% to 268,323 unitsForm 4Open-market sale10b5-1 plan
- Sep 26, 2025-$63KAQSTOfficer Boyd Peter E. sold $63,000 worth of shares (10,000 units at $6.30), decreasing direct ownership by 3% to 278,323 unitsForm 4Open-market sale10b5-1 plan
- Sep 26, 2025~$63KAQSTPeter E. Boyd plans to sell 10,000 shares (~$63K)Form 144Planned sale10b5-1 plan
- Sep 5, 2025-$79.5KAQSTOfficer Boyd Peter E. sold $79,500 worth of shares (15,000 units at $5.30), decreasing direct ownership by 5% to 288,323 unitsForm 4Open-market sale10b5-1 plan
- Mar 9, 2025AQSTSee Remark Boyd Peter E. was granted 80,000 shares and covered exercise/tax liability with 14,305 shares, increasing direct ownership by 28% to 303,323 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Mar 9, 2024AQSTBoyd Peter E. covered exercise/tax liability with 8,370 shares, decreasing direct ownership by 3% to 237,628 unitsForm 4Shares withheld for taxes or exercise price
- Mar 7, 2024AQSTBoyd Peter E. was granted 86,250 shares, increasing direct ownership by 54% to 245,998 unitsForm 4Grant or award
- Aug 9, 2023AQSTSEC Form 4 filed by Boyd Peter E.Form 4Grant or award
- May 5, 2023AQSTSEC Form 4 filed by Boyd Peter E.Form 4Grant or award
- Mar 9, 2023AQSTSEC Form 4: Boyd Peter E. was granted 100,000 shares, increasing direct ownership by 168% to 159,532 unitsForm 4Grant or award
- Nov 4, 2022AQSTSEC Form 4 filed by Boyd Peter E.Form 4Grant or award
- Jun 14, 2022+$4,050AQSTSEC Form 4: Boyd Peter E. bought $4,050 worth of shares (5,000 units at $0.81), increasing direct ownership by 9% to 59,532 unitsForm 4Open-market purchase
- Jun 8, 2022+$2,201AQSTSEC Form 4: Boyd Peter E. bought $2,201 worth of shares (2,293 units at $0.96), increasing direct ownership by 4% to 54,532 unitsForm 4Open-market purchase
- Mar 10, 2022AQSTSEC Form 4 filed by Boyd Peter E.Form 4Grant or award
- Mar 11, 2021AQSTSEC Form 4 filed by E. Peter BoydForm 4Grant or award
Compare Peter E. Boyd with
- Peter E. Boyd vs Daniel Barber1 shared
- Peter E. Boyd vs Sherry Korczynski1 shared
- Peter E. Boyd vs Cassie Jung1 shared
- Peter E. Boyd vs Julie Krop1 shared
- Peter E. Boyd vs Timothy E Morris1 shared
- Peter E. Boyd vs Abigail L. Jenkins1 shared
Other insiders at the same companies
- Daniel BarberAQST
- Sherry KorczynskiAQST
- Cassie JungAQST
- Julie KropAQST
- Timothy E MorrisAQST
- Abigail L. JenkinsAQST
- John CochranAQST
- Gregory B BrownAQST
- Marco TagliettiAQST
- Thomas A. ZalewskiAQST
- Melina CioffiAQST
- Lori J BraenderAQST
- A Ernest Toth JrAQST
- Matthew W. DavisAQST
- Matthew J. GreenhawtAQST
- Carl N KrausAQST
Questions about Peter E. Boyd
- What is Peter E. Boyd's role at Aquestive Therapeutics, Inc.?
- Peter E. Boyd reports to the SEC as chief People Officer at Aquestive Therapeutics, Inc. (AQST), according to the latest filing on September 10, 2026.
- How many shares does Peter E. Boyd own?
- After the latest filing that states it, Peter E. Boyd directly owned 284,024 shares of Aquestive Therapeutics, Inc. (AQST). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Peter E. Boyd bought or sold stock recently?
- The most recent open-market purchase was on June 14, 2022: bought 5,000 shares of Aquestive Therapeutics, Inc. (AQST) for $4,050 at an average of $0.81. The most recent open-market sale was on March 10, 2026: sold 29,814 shares of Aquestive Therapeutics, Inc. (AQST) for $124K at an average of $4.17.
- How do I get alerts when Peter E. Boyd files?
- Follow Peter E. Boyd on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Peter E. Boyd filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Peter E. Boyd (SEC CIK 0001739816). Totals count each trade once, skipping amendments whose original is on file, from Mar 15, 2021 on. View on SEC EDGAR